Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

bluebird bio Inc (NASDAQ:BLUE)

77.10
Delayed Data
As of Feb 17
 +0.55 / +0.72%
Today’s Change
35.37
Today|||52-Week Range
81.25
+24.96%
Year-to-Date
Watching for More Movement in Bluebird BIO and 3 Others
Feb 15 / TheStreet.com - Paid Partner Content
3 Scorching Hot Biotech Stocks -- Are They Buys?
Feb 08 / MotleyFool.com - Paid Partner Content
Why bluebird bio Stock Surged 20.7% Higher in January
Feb 09 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close76.55
Today’s open76.40
Day’s range75.10 - 77.55
Volume668,939
Average volume (3 months)1,167,317
Market cap$3.1B
Dividend yield--
Data as of 4:00pm ET, 02/17/2017

Growth & Valuation

Earnings growth (last year)-162.84%
Earnings growth (this year)-47.01%
Earnings growth (next 5 years)-23.75%
Revenue growth (last year)-44.62%
P/E ratioNM
Price/Sales158.14
Price/Book3.34

Competitors

 Today’s
change
Today’s
% change
XONIntrexon Corp-0.14-0.59%
KITEKite Pharma Inc+0.19+0.35%
JUNOJuno Therapeutics In...-0.10-0.43%
NBIXNeurocrine Bioscienc...+0.90+2.09%
Data as of 4:02pm ET, 02/17/2017

Financials

Next reporting dateMarch 1, 2017
EPS forecast (this quarter)-$1.88
Annual revenue (last year)$14.1M
Annual profit (last year)-$166.8M
Net profit margin-1,184.62%

Profile

Sector
Health Technology
Industry
Biotechnology
President &
Chief Executive Officer
Nick Leschly
Chief Operating Officer
Susanna G. High
Corporate headquarters
Cambridge, Massachusetts

Forecasts


Search for Jobs